Vimarsana
Biggest News Aggregation in the World

Page 25 - Mitsui News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mitsui. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mitsui Today - Breaking & Trending Today

Beach announces delay, cost increase for Waitsia Stage 2 gas project - Vimarsana News

Beach announces delay, cost increase for Waitsia Stage 2 gas project

The fresh delay and cost escalation are due to quality issues encountered during pre-commissioning activities.

Deals in brief: Smartpay and WYZauto secure funding, SGX-listed APS to acquire Mobii Network, seven China deals, and more - Vimarsana News

Deals in brief: Smartpay and WYZauto secure funding, SGX-listed APS to acquire Mobii Network, seven China deals, and more

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

Japan Offshore Wind Update – Round 2 Results & Round 3 Process | White & Case LLP - Vimarsana News

Japan Offshore Wind Update – Round 2 Results & Round 3 Process | White & Case LLP

The Japanese government released the results of the remaining "Round 2" offshore wind auctions. A consortium of Japanese and foreign developers was selected. Meanwhile, the next "Round...

Deals in brief: Pro-Net secures MYR 200 million from CIMB Bank, Mitsui and Rohto jointly acquire Eu Yan Sang, Hyundai becomes top shareholder of KT, and more - Vimarsana News

Deals in brief: Pro-Net secures MYR 200 million from CIMB Bank, Mitsui and Rohto jointly acquire Eu Yan Sang, Hyundai becomes top shareholder of KT, and more

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

Mitsui and Rohto to buy Eu Yan Sang for $800m - Vimarsana News

Mitsui and Rohto to buy Eu Yan Sang for $800m

SINGAPORE- Japan's Mitsui & Co, said on Thursday (April 4) it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million. Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86 per cent of...